Bayview Legacy, LLC has disclosed recent stock transactions involving common shares of Arteris, Inc. The transactions, reported in a filing dated November 4, 2026, are significant as they reflect the strategic trading activities of the company within the semiconductor sector.

Bayview Legacy, LLC, incorporated in Delaware, is a relatively new player in the market. It was previously known as Arteris IP, LLC until a name change on October 19, 2021. The company operates from Campbell, California, and is actively involved in managing its investments in various entities.

The filing reveals that Bayview Legacy executed two significant transactions on November 2, 2026. The first transaction involved the sale of 95,099 shares of Arteris, Inc. at a weighted average price of $18.1856 per share. The second transaction involved the sale of 4,901 shares at a weighted average price of $18.8147. Following these transactions, Bayview Legacy holds a total of 8,033,972 shares of Arteris, Inc.

These transactions are noteworthy as they were made under a 10b5-1 trading plan, which was adopted by K. Charles Janac, the manager of Bayview Legacy, on December 12, 2025. This plan allows for predetermined trading schedules, which can help avoid accusations of insider trading. Janac also reported these transactions in his individual capacity, indicating his direct involvement with the shares.

The impact of these transactions may extend to various stakeholders, including shareholders of Arteris, Inc., as changes in ownership can influence market dynamics and investor sentiment. Additionally, the semiconductor industry, represented by Arteris, could see shifts in trading patterns as a result of these activities.

Details regarding future actions following this filing were not specified. Investors and interested parties may look for further updates or additional filings from Bayview Legacy or Arteris, Inc. to gain more insights into ongoing trading strategies and market implications.